These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10697745)

  • 1. Vascular endothelial growth factor and basic fibroblast growth factor evaluation in blood serum of patients with hormonally active and inactive adrenal gland tumours.
    Kołomecki K; Stepień H; Narebski JM
    Cytobios; 2000; 101(396):55-64. PubMed ID: 10697745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of VEGF, MMP-2, MMP-3 and TIMP-2 serum level evaluation in patients with adrenal tumours.
    Kolomecki K; Stepien H; Bartos M; Kuzdak K
    Endocr Regul; 2001 Mar; 35(1):9-16. PubMed ID: 11308991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Independent expression of serum vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in patients with carcinoma and sarcoma.
    Linder C; Linder S; Munck-Wikland E; Strander H
    Anticancer Res; 1998; 18(3B):2063-8. PubMed ID: 9677468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of MMP-1, MMP-8, MMP-9 serum levels in patients with adrenal tumors prior to and after surgery.
    Kołomecki K; Stepień H; Bartos M; Narebski J
    Neoplasma; 2001; 48(2):116-21. PubMed ID: 11478691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) and soluble interleukin-2 receptor (sIL-2R) concentrations in peripheral blood as markers of pituitary tumours.
    Komorowski J; Jankewicz J; Stepień H
    Cytobios; 2000; 101(398):151-9. PubMed ID: 10755214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood.
    Di Raimondo F; Azzaro MP; Palumbo G; Bagnato S; Giustolisi G; Floridia P; Sortino G; Giustolisi R
    Haematologica; 2000 Aug; 85(8):800-5. PubMed ID: 10942925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity.
    Robak E; Woźniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
    Eur Cytokine Netw; 2001; 12(3):445-52. PubMed ID: 11566625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are basic fibroblast growth factor and vascular endothelial growth factor prognostic indicators in pediatric patients with malignant solid tumors?
    Tabone MD; Landman-Parker J; Arcil B; Coudert MC; Gerota I; Benbunan M; Leverger G; Dosquet C
    Clin Cancer Res; 2001 Mar; 7(3):538-43. PubMed ID: 11297245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of vascular endothelial growth factor expression with fibroblast growth factor-8 expression and clinico-pathologic parameters in human prostate cancer.
    West AF; O'Donnell M; Charlton RG; Neal DE; Leung HY
    Br J Cancer; 2001 Aug; 85(4):576-83. PubMed ID: 11506499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesis.
    Braybrooke JP; O'Byrne KJ; Propper DJ; Blann A; Saunders M; Dobbs N; Han C; Woodhull J; Mitchell K; Crew J; Smith K; Stephens R; Ganesan TS; Talbot DC; Harris AL
    Clin Cancer Res; 2000 Dec; 6(12):4697-704. PubMed ID: 11156222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor (VEGF)--a valuable serum tumour marker in patients with colorectal cancer?
    Broll R; Erdmann H; Duchrow M; Oevermann E; Schwandner O; Markert U; Bruch HP; Windhövel U
    Eur J Surg Oncol; 2001 Feb; 27(1):37-42. PubMed ID: 11237490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenic factors: vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (b-FGF) are not necessarily elevated in patients with advanced renal cell carcinoma.
    Edgren M; Lennernäs B; Larsson A; Kälkner KM
    Anticancer Res; 2001; 21(2B):1423-9. PubMed ID: 11396226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor in angiosarcoma.
    Fujimoto M; Kiyosawa T; Murata S; Matsuo K; Suzuki H; Sone H; Okuda Y; Nakayama Y; Yaoita H
    Anticancer Res; 1998; 18(5B):3725-9. PubMed ID: 9854484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma vascular endothelial but not fibroblast growth factor levels correlate with colorectal liver mestastasis vascularity and volume.
    Davies MM; Jonas SK; Kaur S; Allen-Mersh TG
    Br J Cancer; 2000 Mar; 82(5):1004-8. PubMed ID: 10737380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of multimodality therapy on circulating vascular endothelial growth factor levels in patients with oesophageal cancer.
    McDonnell CO; Harmey JH; Bouchier-Hayes DJ; Walsh TN
    Br J Surg; 2001 Aug; 88(8):1105-9. PubMed ID: 11488797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes.
    Aguayo A; Kantarjian HM; Estey EH; Giles FJ; Verstovsek S; Manshouri T; Gidel C; O'Brien S; Keating MJ; Albitar M
    Cancer; 2002 Nov; 95(9):1923-30. PubMed ID: 12404286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of plasma vascular endothelial growth factor in patients with colorectal cancer.
    Nakayama Y; Sako T; Shibao K; Okazaki K; Rempo N; Onitsuka K; Minagawa N; Akahane K; Nagashima N; Nagata N; Itoh H
    Anticancer Res; 2002; 22(4):2437-42. PubMed ID: 12174940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical significance of vascular endothelial growth factor in sera of patients with gynaecological malignant tumors].
    Peng XP; Li JD; Li MD; Ye XM; Yan WC
    Ai Zheng; 2002 Feb; 21(2):181-5. PubMed ID: 12479072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between plasma levels of vascular endothelial growth factor and serum levels of interleukin-12 in patients with colorectal cancer.
    Nakayama Y; Sako T; Shibao K; Onitsuka K; Nagashima N; Hirata K; Nagata N; Itoh H
    Anticancer Res; 2000; 20(6A):4097-102. PubMed ID: 11131678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma].
    Zhao J; Hu J; Cai J
    Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):389-92. PubMed ID: 11810769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.